Gainers
- Jin Medical International ZJYL shares moved upwards by 94.4% to $137.0 during Monday's regular session. The market value of their outstanding shares is at $1.0 billion.
- Karuna Therapeutics KRTX stock increased by 47.71% to $317.87. The market value of their outstanding shares is at $11.9 billion.
- IMAC Hldgs BACK shares moved upwards by 42.59% to $2.31. The market value of their outstanding shares is at $2.6 million.
- Pasithea Therapeutics KTTA shares rose 32.86% to $0.38. The market value of their outstanding shares is at $7.9 million.
- PureTech Health PRTC stock moved upwards by 31.3% to $25.0. The market value of their outstanding shares is at $679.8 million.
- Renalytix RNLX shares increased by 30.4% to $0.45. The company's market cap stands at $22.4 million.
Losers
- AlloVir ALVR stock fell 66.2% to $0.79 during Monday's regular session. The company's market cap stands at $89.7 million.
- Cyclacel Pharmaceuticals CYCC shares decreased by 23.89% to $2.74. The market value of their outstanding shares is at $2.3 million.
- 60 Degrees SXTP shares decreased by 17.28% to $0.91. The market value of their outstanding shares is at $5.2 million.
- HOOKIPA Pharma HOOK shares fell 16.41% to $0.72. The market value of their outstanding shares is at $60.5 million.
- Theriva Biologics TOVX shares fell 15.24% to $0.43. The company's market cap stands at $7.3 million.
- Nanobiotix NBTX stock declined by 14.72% to $6.55. The market value of their outstanding shares is at $308.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
BACKIMAC Holdings Inc
$1.218.04%
CYCCCyclacel Pharmaceuticals Inc
$0.33300.60%
HOOKHOOKIPA Pharma Inc
$2.14-%
KTTAPasithea Therapeutics Corp
$2.9912.0%
NBTXNanobiotix SA
$3.10-5.49%
PRTCPureTech Health PLC
$20.90-0.86%
SXTP60 Degrees Pharmaceuticals Inc
$1.26-10.6%
TOVXTheriva Biologics Inc
$1.10-4.35%
ZJYLJin Medical International Ltd
$0.86001.19%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in